Related Experiment Videos
Renal cell carcinoma
1Section on Hematology/Oncology, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1082.
Abstract:
Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemotherapy remain disappointing, advances in immunotherapy as well as our basic understanding of the renal carcinoma cell have been made. Translation into clinical trials will likely occur within the next few years based on these findings.
Insights
Renal cell carcinoma (RCC) treatment remains challenging. Recent advances in immunotherapy and understanding of the cancer cell offer hope for new clinical trials and improved patient outcomes in the near future.
Area of Science:
- Oncology
- Immunology
Background:
- Renal cell carcinoma (RCC) presents significant treatment challenges.
- Current cure rates for RCC, especially advanced stages, remain low despite surgery and immunotherapy.
- Chemotherapy and early detection methods have shown limited success.
Purpose of the Study:
- To summarize recent advancements in understanding renal cell carcinoma.
- To highlight progress in immunotherapy for RCC.
- To discuss the potential translation of basic science findings into clinical applications.
Main Methods:
- Review of current literature on renal cell carcinoma.
- Analysis of recent breakthroughs in cancer immunology.
- Assessment of the biological understanding of renal carcinoma cells.
Main Results:
- Significant progress has been made in understanding the basic biology of renal carcinoma cells.
- Advances in immunotherapy have shown promise for treating advanced RCC.
- Despite challenges, new therapeutic strategies are emerging.
Conclusions:
- Further research into RCC biology and immunotherapy is crucial.
- Translational research holds promise for developing novel treatments.
- Clinical trials based on recent findings are anticipated in the coming years.